SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 399 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $72,533,000 | -99.8% | 426,867 | 0.0% | 0.56% | +20.0% |
| Q1 2020 | $47,484,685,000 | -2.6% | 426,867 | 0.0% | 0.47% | +42.9% |
| Q4 2019 | $48,773,823,000 | +132932.8% | 426,867 | -14.7% | 0.33% | +25.9% |
| Q1 2019 | $36,663,000 | +38.2% | 500,595 | +6.9% | 0.26% | +15.1% |
| Q4 2018 | $26,536,000 | -18.4% | 468,343 | +11.1% | 0.22% | -3.4% |
| Q3 2018 | $32,502,000 | +23.7% | 421,456 | +6.5% | 0.23% | +12.6% |
| Q2 2018 | $26,267,000 | – | 395,659 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |